Neoadjuvant anti-PD-1 immunotherapy promotes a survival benefit with intratumoral and systemic immune responses in recurrent glioblastoma
Timothy F. Cloughesy(University of California, Los Angeles), Aaron Mochizuki(University of California, Los Angeles), Joey Orpilla(University of California, Los Angeles), Willy Hugo(University of California, Los Angeles), Alex Lee(University of California, Los Angeles), Tom B. Davidson(University of California, Los Angeles), Anthony Wang(University of California, Los Angeles), Benjamin M. Ellingson(University of California, Los Angeles), Julie Rytlewski(Adaptive Biotechnologies (United States)), Catherine Sanders(Adaptive Biotechnologies (United States)), Eric S. Kawaguchi(University of California, Los Angeles), Lin Du(University of California, Los Angeles), Gang Li(University of California, Los Angeles), William H. Yong(University of California, Los Angeles), Sarah Gaffey(Center for Neuro-Oncology), Adam L. Cohen(University of Utah), Ingo K. Mellinghoff(Memorial Sloan Kettering Cancer Center), Eudocia Q. Lee(Center for Neuro-Oncology), David A. Reardon(Center for Neuro-Oncology), Barbara O’Brien(The University of Texas MD Anderson Cancer Center), Nicholas Butowski(University of California, San Francisco), Phioanh L. Nghiemphu(University of California, Los Angeles), Jennifer Clarke(University of California, San Francisco), Isabel Arrillaga‐Romany(Massachusetts General Hospital), Howard Colman(University of Utah), Thomas Kaley(Memorial Sloan Kettering Cancer Center), John de Groot(The University of Texas MD Anderson Cancer Center), Linda M. Liau(University of California, Los Angeles), Patrick Y. Wen(Center for Neuro-Oncology), Robert M. Prins(University of California, Los Angeles)
Cited by 1,380
Abstract
Related Papers
No related papers found
Powered by citation graph analysis